Although the number of cases studied here is limited, the intent was not to undertake a detailed topographic analysis of tau deposition across all tauopathies, but rather to determine whether the proposed pathway of pThr175 tau mediated induction of pThr231 tau formation with its attendant pathological tau fibril formation (as recognized by T22) was evident. The gene discussed is MAPT; the disease is tauopathy.